Abstract
Continuous subcutaneous infusion of foslevodopa/foscarbidopa (LDP/CDP) may be effective in improving daytime symptoms in patients with Parkinson’s disease (PD). We report on a PD patient for whom LDP/CDP treatment improved motor symptoms, sleep disturbances and sleep architecture as measured by the mobile two-channel electroencephalography/electrooculography recording system.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
